Ramin Najafi, Chief Executive Officer, 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY), bought 12,000 shares at $0.50 ($6K) on 2015-08-19, disclosed to the SEC on 2015-08-21.
Open-market purchase of $6k NBY by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.50 | 6,000 | $3K | 53.2% |
| 2 | $0.44 | 6,000 | $3K | 46.8% |
| Total | $0.47 avg | 12,000 | $6K | 100% |
| Filing → |
| NBY | BUY | 2014-12-11 | $12K | — | Filing → |
| NBY | BUY | 2014-12-08 | $16K | — | Filing → |
| NBY | BUY | 2014-12-04 | $13K | — | Filing → |